Dyne Therapeutics (DYN) Amortizatization of Intangibles (2020)

Dyne Therapeutics (DYN) recorded quarterly Amortizatization of Intangibles of $1000.0 in Q2 2020, down 91.67% quarter-over-quarter from $12000.0 in Q1 2020.

Dyne Therapeutics (DYN) Amortizatization of Intangibles (2020) Analysis & Trends

Dyne Therapeutics' Amortizatization of Intangibles history runs 1 years deep, the most recent figure standing at $1000.0 for Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 13,267.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Dyne Therapeutics 3.00 Bn 3.00 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2020 1,000.00
Jun 30, 2020 1,000.00
Mar 31, 2020 12,000.00
Mar 31, 2020 12,000.00